Article
Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment.
Clinics in liver disease - 1 Aug 2017
Pozzato Gabriele, Mazzaro Cesare, Gattei Valter
Abstract excerpt
Eradication of hepatitis C virus (HCV) in indolent non-Hodgkin lymphomas (NHLs), especially in marginal zone lymphomas, determines the regression of the hematologic disorder in a significant fraction of cases. Because direct antiviral agents show an excellent profile in terms of efficacy, safety, and rapid onset of action, these drugs can be used in any clinical situation and in the presence of any comorbidities....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
